Format

Send to

Choose Destination
Clin Infect Dis. 2002 Feb 1;34(3):394-7. Epub 2001 Dec 19.

Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy.

Author information

1
Services of Infectious Diseases , Hospital Gregorio Marañón, 28007, Madrid, Spain. juaberber@eresmas.net

Abstract

We performed a prospective study of discontinuation of secondary prophylaxis against cytomegalovirus (CMV) in 36 patients with acquired immunodeficiency syndrome and quiescent CMV retinitis after successful treatment with highly active antiretroviral therapy (HAART). No reactivation or progression of retinitis was observed in 35 patients with persistent response to HAART, findings that support the discontinuation of secondary prophylaxis against CMV retinitis in such patients.

PMID:
11753827
DOI:
10.1086/338401
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center